nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2C18—Ifosfamide—testicular cancer	0.216	0.299	CbGbCtD
Perphenazine—AOX1—Methotrexate—testicular cancer	0.113	0.156	CbGbCtD
Perphenazine—CYP2B6—Ifosfamide—testicular cancer	0.0684	0.0946	CbGbCtD
Perphenazine—CYP2C8—Ifosfamide—testicular cancer	0.0518	0.0717	CbGbCtD
Perphenazine—CYP2C19—Ifosfamide—testicular cancer	0.0435	0.0601	CbGbCtD
Perphenazine—CYP2C9—Ifosfamide—testicular cancer	0.0362	0.05	CbGbCtD
Perphenazine—CYP2B6—Cisplatin—testicular cancer	0.0333	0.046	CbGbCtD
Perphenazine—CYP2C8—Etoposide—testicular cancer	0.0248	0.0343	CbGbCtD
Perphenazine—HTR7—vas deferens—testicular cancer	0.0225	0.235	CbGeAlD
Perphenazine—CYP2B6—Doxorubicin—testicular cancer	0.0223	0.0308	CbGbCtD
Perphenazine—CYP3A4—Ifosfamide—testicular cancer	0.021	0.0291	CbGbCtD
Perphenazine—CYP1A2—Etoposide—testicular cancer	0.0192	0.0265	CbGbCtD
Perphenazine—CYP2C9—Cisplatin—testicular cancer	0.0176	0.0243	CbGbCtD
Perphenazine—CYP2D6—Vinblastine—testicular cancer	0.0175	0.0242	CbGbCtD
Perphenazine—CYP3A4—Vinblastine—testicular cancer	0.0112	0.0154	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—testicular cancer	0.0108	0.0149	CbGbCtD
Perphenazine—CYP3A4—Etoposide—testicular cancer	0.01	0.0139	CbGbCtD
Perphenazine—HTR7—vein—testicular cancer	0.00956	0.0998	CbGeAlD
Perphenazine—CALM2—semen—testicular cancer	0.00825	0.086	CbGeAlD
Perphenazine—CALM1—semen—testicular cancer	0.00821	0.0856	CbGeAlD
Perphenazine—CYP3A4—Doxorubicin—testicular cancer	0.00685	0.00947	CbGbCtD
Perphenazine—HTR2A—vein—testicular cancer	0.00596	0.0622	CbGeAlD
Perphenazine—AOX1—seminal vesicle—testicular cancer	0.00247	0.0258	CbGeAlD
Perphenazine—CALM3—seminal vesicle—testicular cancer	0.00223	0.0232	CbGeAlD
Perphenazine—CALM2—embryo—testicular cancer	0.00186	0.0194	CbGeAlD
Perphenazine—CALM1—embryo—testicular cancer	0.00185	0.0193	CbGeAlD
Perphenazine—AOX1—gonad—testicular cancer	0.00179	0.0186	CbGeAlD
Perphenazine—CALM2—seminal vesicle—testicular cancer	0.00175	0.0182	CbGeAlD
Perphenazine—AOX1—female gonad—testicular cancer	0.00145	0.0151	CbGeAlD
Perphenazine—CALM3—female gonad—testicular cancer	0.00131	0.0136	CbGeAlD
Perphenazine—AOX1—testis—testicular cancer	0.00129	0.0134	CbGeAlD
Perphenazine—CALM2—gonad—testicular cancer	0.00126	0.0132	CbGeAlD
Perphenazine—CALM1—gonad—testicular cancer	0.00126	0.0131	CbGeAlD
Perphenazine—ADRA2A—seminal vesicle—testicular cancer	0.00125	0.013	CbGeAlD
Perphenazine—HTR7—gonad—testicular cancer	0.00123	0.0128	CbGeAlD
Perphenazine—CALM3—testis—testicular cancer	0.00116	0.0121	CbGeAlD
Perphenazine—HTR2A—embryo—testicular cancer	0.00113	0.0118	CbGeAlD
Perphenazine—CALM2—female gonad—testicular cancer	0.00103	0.0107	CbGeAlD
Perphenazine—CALM1—female gonad—testicular cancer	0.00102	0.0107	CbGeAlD
Perphenazine—CYP2B6—gonad—testicular cancer	0.000939	0.0098	CbGeAlD
Perphenazine—AOX1—lymph node—testicular cancer	0.000933	0.00974	CbGeAlD
Perphenazine—CALM2—testis—testicular cancer	0.000911	0.0095	CbGeAlD
Perphenazine—CALM1—testis—testicular cancer	0.000906	0.00946	CbGeAlD
Perphenazine—ADRA2A—gonad—testicular cancer	0.000901	0.0094	CbGeAlD
Perphenazine—HTR7—testis—testicular cancer	0.000885	0.00924	CbGeAlD
Perphenazine—CALM3—lymph node—testicular cancer	0.00084	0.00877	CbGeAlD
Perphenazine—DRD2—testis—testicular cancer	0.000837	0.00873	CbGeAlD
Perphenazine—HTR2A—gonad—testicular cancer	0.000766	0.00799	CbGeAlD
Perphenazine—CYP2C8—testis—testicular cancer	0.000755	0.00787	CbGeAlD
Perphenazine—HRH1—female gonad—testicular cancer	0.000745	0.00778	CbGeAlD
Perphenazine—ADRA2A—female gonad—testicular cancer	0.000732	0.00764	CbGeAlD
Perphenazine—CYP2B6—testis—testicular cancer	0.000677	0.00706	CbGeAlD
Perphenazine—HRH1—testis—testicular cancer	0.000661	0.0069	CbGeAlD
Perphenazine—CALM2—lymph node—testicular cancer	0.00066	0.00689	CbGeAlD
Perphenazine—CALM1—lymph node—testicular cancer	0.000657	0.00685	CbGeAlD
Perphenazine—ADRA2A—testis—testicular cancer	0.000649	0.00678	CbGeAlD
Perphenazine—CYP2D6—female gonad—testicular cancer	0.000567	0.00592	CbGeAlD
Perphenazine—HTR2A—testis—testicular cancer	0.000552	0.00576	CbGeAlD
Perphenazine—CYP2D6—testis—testicular cancer	0.000503	0.00525	CbGeAlD
Perphenazine—Dermatitis contact—Epirubicin—testicular cancer	0.000481	0.00287	CcSEcCtD
Perphenazine—Abnormal dreams—Epirubicin—testicular cancer	0.000481	0.00287	CcSEcCtD
Perphenazine—Erythema—Ifosfamide—testicular cancer	0.00048	0.00286	CcSEcCtD
Perphenazine—HRH1—lymph node—testicular cancer	0.000479	0.005	CbGeAlD
Perphenazine—Dyskinesia—Doxorubicin—testicular cancer	0.000479	0.00286	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—testicular cancer	0.000476	0.00284	CcSEcCtD
Perphenazine—Jaundice—Etoposide—testicular cancer	0.000473	0.00282	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—testicular cancer	0.000472	0.00282	CcSEcCtD
Perphenazine—Decreased appetite—Vinblastine—testicular cancer	0.000472	0.00282	CcSEcCtD
Perphenazine—Urticaria—Chlorambucil—testicular cancer	0.000471	0.00281	CcSEcCtD
Perphenazine—ADRA2A—lymph node—testicular cancer	0.000471	0.00491	CbGeAlD
Perphenazine—Urine output increased—Methotrexate—testicular cancer	0.00047	0.0028	CcSEcCtD
Perphenazine—Leukopenia—Dactinomycin—testicular cancer	0.000469	0.0028	CcSEcCtD
Perphenazine—Body temperature increased—Chlorambucil—testicular cancer	0.000468	0.00279	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—testicular cancer	0.000465	0.00277	CcSEcCtD
Perphenazine—Constipation—Vinblastine—testicular cancer	0.000464	0.00277	CcSEcCtD
Perphenazine—Pain—Vinblastine—testicular cancer	0.000464	0.00277	CcSEcCtD
Perphenazine—Confusional state—Bleomycin—testicular cancer	0.000462	0.00276	CcSEcCtD
Perphenazine—Anaphylactic shock—Bleomycin—testicular cancer	0.000459	0.00274	CcSEcCtD
Perphenazine—Infection—Bleomycin—testicular cancer	0.000456	0.00272	CcSEcCtD
Perphenazine—Agranulocytosis—Etoposide—testicular cancer	0.000453	0.0027	CcSEcCtD
Perphenazine—Vision blurred—Ifosfamide—testicular cancer	0.000453	0.0027	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—testicular cancer	0.00045	0.00268	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—testicular cancer	0.000445	0.00265	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—testicular cancer	0.000445	0.00265	CcSEcCtD
Perphenazine—Agitation—Ifosfamide—testicular cancer	0.000441	0.00263	CcSEcCtD
Perphenazine—Angioedema—Ifosfamide—testicular cancer	0.000439	0.00262	CcSEcCtD
Perphenazine—Anorexia—Bleomycin—testicular cancer	0.000437	0.00261	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—testicular cancer	0.000437	0.00261	CcSEcCtD
Perphenazine—Hypersensitivity—Chlorambucil—testicular cancer	0.000437	0.0026	CcSEcCtD
Perphenazine—Hypoaesthesia—Etoposide—testicular cancer	0.000434	0.00259	CcSEcCtD
Perphenazine—Leukopenia—Ifosfamide—testicular cancer	0.00043	0.00256	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—testicular cancer	0.00043	0.00256	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—testicular cancer	0.00043	0.00256	CcSEcCtD
Perphenazine—Hypotension—Bleomycin—testicular cancer	0.000429	0.00256	CcSEcCtD
Perphenazine—Infection—Dactinomycin—testicular cancer	0.000425	0.00253	CcSEcCtD
Perphenazine—Pruritus—Chlorambucil—testicular cancer	0.000419	0.0025	CcSEcCtD
Perphenazine—Cough—Ifosfamide—testicular cancer	0.000419	0.0025	CcSEcCtD
Perphenazine—Convulsion—Ifosfamide—testicular cancer	0.000416	0.00248	CcSEcCtD
Perphenazine—Hypertension—Ifosfamide—testicular cancer	0.000415	0.00247	CcSEcCtD
Perphenazine—Erythema—Cisplatin—testicular cancer	0.000414	0.00247	CcSEcCtD
Perphenazine—Dyspnoea—Bleomycin—testicular cancer	0.000409	0.00244	CcSEcCtD
Perphenazine—Anorexia—Dactinomycin—testicular cancer	0.000408	0.00243	CcSEcCtD
Perphenazine—Diarrhoea—Chlorambucil—testicular cancer	0.000405	0.00242	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—testicular cancer	0.000402	0.0024	CcSEcCtD
Perphenazine—Hypersensitivity—Vinblastine—testicular cancer	0.0004	0.00239	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.0004	0.00239	CcSEcCtD
Perphenazine—Decreased appetite—Bleomycin—testicular cancer	0.000399	0.00238	CcSEcCtD
Perphenazine—Muscle spasms—Cisplatin—testicular cancer	0.000398	0.00237	CcSEcCtD
Perphenazine—Confusional state—Ifosfamide—testicular cancer	0.000395	0.00236	CcSEcCtD
Perphenazine—Eczema—Epirubicin—testicular cancer	0.000393	0.00234	CcSEcCtD
Perphenazine—Pain—Bleomycin—testicular cancer	0.000392	0.00234	CcSEcCtD
Perphenazine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000392	0.00234	CcSEcCtD
Perphenazine—Vision blurred—Cisplatin—testicular cancer	0.00039	0.00233	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00039	0.00233	CcSEcCtD
Perphenazine—Infection—Ifosfamide—testicular cancer	0.000389	0.00232	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—testicular cancer	0.000385	0.0023	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000374	0.00223	CcSEcCtD
Perphenazine—Anorexia—Ifosfamide—testicular cancer	0.000374	0.00223	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—testicular cancer	0.000372	0.00222	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—testicular cancer	0.000372	0.00222	CcSEcCtD
Perphenazine—Diarrhoea—Vinblastine—testicular cancer	0.000372	0.00222	CcSEcCtD
Perphenazine—Leukopenia—Cisplatin—testicular cancer	0.000371	0.00221	CcSEcCtD
Perphenazine—Hypotension—Ifosfamide—testicular cancer	0.000366	0.00218	CcSEcCtD
Perphenazine—Pain—Dactinomycin—testicular cancer	0.000366	0.00218	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000365	0.00218	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—testicular cancer	0.000365	0.00218	CcSEcCtD
Perphenazine—Urticaria—Bleomycin—testicular cancer	0.000364	0.00217	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—testicular cancer	0.000364	0.00217	CcSEcCtD
Perphenazine—Body temperature increased—Bleomycin—testicular cancer	0.000363	0.00216	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—testicular cancer	0.000362	0.00216	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—testicular cancer	0.00036	0.00215	CcSEcCtD
Perphenazine—Dizziness—Vinblastine—testicular cancer	0.000359	0.00214	CcSEcCtD
Perphenazine—Convulsion—Cisplatin—testicular cancer	0.000359	0.00214	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—testicular cancer	0.000355	0.00212	CcSEcCtD
Perphenazine—Dyspnoea—Ifosfamide—testicular cancer	0.000349	0.00208	CcSEcCtD
Perphenazine—Somnolence—Ifosfamide—testicular cancer	0.000348	0.00208	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000346	0.00207	CcSEcCtD
Perphenazine—Decreased appetite—Ifosfamide—testicular cancer	0.000341	0.00203	CcSEcCtD
Perphenazine—Headache—Vinblastine—testicular cancer	0.00034	0.00203	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—testicular cancer	0.00034	0.00203	CcSEcCtD
Perphenazine—Body temperature increased—Dactinomycin—testicular cancer	0.000338	0.00202	CcSEcCtD
Perphenazine—Anaphylactic shock—Cisplatin—testicular cancer	0.000338	0.00202	CcSEcCtD
Perphenazine—Hypersensitivity—Bleomycin—testicular cancer	0.000338	0.00202	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000338	0.00201	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—testicular cancer	0.000336	0.002	CcSEcCtD
Perphenazine—Infection—Cisplatin—testicular cancer	0.000336	0.002	CcSEcCtD
Perphenazine—Pain—Ifosfamide—testicular cancer	0.000335	0.002	CcSEcCtD
Perphenazine—Constipation—Ifosfamide—testicular cancer	0.000335	0.002	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—testicular cancer	0.000335	0.002	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—testicular cancer	0.000333	0.00199	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—testicular cancer	0.000333	0.00199	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—testicular cancer	0.000332	0.00198	CcSEcCtD
Perphenazine—Cough—Etoposide—testicular cancer	0.000331	0.00197	CcSEcCtD
Perphenazine—Tachycardia—Cisplatin—testicular cancer	0.00033	0.00197	CcSEcCtD
Perphenazine—Convulsion—Etoposide—testicular cancer	0.000329	0.00196	CcSEcCtD
Perphenazine—Hypertension—Etoposide—testicular cancer	0.000327	0.00195	CcSEcCtD
Perphenazine—Asthma—Methotrexate—testicular cancer	0.000326	0.00195	CcSEcCtD
Perphenazine—Pruritus—Bleomycin—testicular cancer	0.000324	0.00194	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—testicular cancer	0.000323	0.00193	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—testicular cancer	0.000322	0.00192	CcSEcCtD
Perphenazine—Anorexia—Cisplatin—testicular cancer	0.000322	0.00192	CcSEcCtD
Perphenazine—Hypotension—Cisplatin—testicular cancer	0.000316	0.00188	CcSEcCtD
Perphenazine—Hypersensitivity—Dactinomycin—testicular cancer	0.000315	0.00188	CcSEcCtD
Perphenazine—Confusional state—Etoposide—testicular cancer	0.000312	0.00186	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—testicular cancer	0.000311	0.00186	CcSEcCtD
Perphenazine—Urticaria—Ifosfamide—testicular cancer	0.000311	0.00186	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—testicular cancer	0.000311	0.00185	CcSEcCtD
Perphenazine—Body temperature increased—Ifosfamide—testicular cancer	0.00031	0.00185	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—testicular cancer	0.00031	0.00185	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—testicular cancer	0.00031	0.00185	CcSEcCtD
Perphenazine—Infection—Etoposide—testicular cancer	0.000308	0.00183	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—testicular cancer	0.000307	0.00183	CcSEcCtD
Perphenazine—Asthma—Epirubicin—testicular cancer	0.000305	0.00182	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—testicular cancer	0.000305	0.00182	CcSEcCtD
Perphenazine—Tachycardia—Etoposide—testicular cancer	0.000302	0.0018	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—testicular cancer	0.000302	0.0018	CcSEcCtD
Perphenazine—Dyspnoea—Cisplatin—testicular cancer	0.000301	0.0018	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000298	0.00178	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000298	0.00178	CcSEcCtD
Perphenazine—Anorexia—Etoposide—testicular cancer	0.000295	0.00176	CcSEcCtD
Perphenazine—Decreased appetite—Cisplatin—testicular cancer	0.000294	0.00175	CcSEcCtD
Perphenazine—Diarrhoea—Dactinomycin—testicular cancer	0.000293	0.00175	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—testicular cancer	0.000291	0.00173	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—testicular cancer	0.00029	0.00173	CcSEcCtD
Perphenazine—Hypotension—Etoposide—testicular cancer	0.000289	0.00173	CcSEcCtD
Perphenazine—Pain—Cisplatin—testicular cancer	0.000289	0.00172	CcSEcCtD
Perphenazine—Hypersensitivity—Ifosfamide—testicular cancer	0.000289	0.00172	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—testicular cancer	0.000288	0.00172	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—testicular cancer	0.000282	0.00168	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—testicular cancer	0.000282	0.00168	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—testicular cancer	0.00028	0.00167	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000279	0.00166	CcSEcCtD
Perphenazine—Pruritus—Ifosfamide—testicular cancer	0.000277	0.00165	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—testicular cancer	0.000276	0.00165	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—testicular cancer	0.000275	0.00164	CcSEcCtD
Perphenazine—Somnolence—Etoposide—testicular cancer	0.000275	0.00164	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—testicular cancer	0.000272	0.00162	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—testicular cancer	0.000271	0.00162	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—testicular cancer	0.000269	0.00161	CcSEcCtD
Perphenazine—Diarrhoea—Ifosfamide—testicular cancer	0.000268	0.0016	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—testicular cancer	0.000268	0.0016	CcSEcCtD
Perphenazine—Body temperature increased—Cisplatin—testicular cancer	0.000267	0.00159	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—testicular cancer	0.000265	0.00158	CcSEcCtD
Perphenazine—Constipation—Etoposide—testicular cancer	0.000265	0.00158	CcSEcCtD
Perphenazine—Pain—Etoposide—testicular cancer	0.000265	0.00158	CcSEcCtD
Perphenazine—Dizziness—Ifosfamide—testicular cancer	0.000259	0.00155	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000258	0.00154	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000255	0.00152	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—testicular cancer	0.000254	0.00151	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—testicular cancer	0.000252	0.0015	CcSEcCtD
Perphenazine—Hypersensitivity—Cisplatin—testicular cancer	0.000249	0.00149	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—testicular cancer	0.000249	0.00148	CcSEcCtD
Perphenazine—Urticaria—Etoposide—testicular cancer	0.000246	0.00147	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—testicular cancer	0.000245	0.00146	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—testicular cancer	0.000245	0.00146	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—testicular cancer	0.000243	0.00145	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—testicular cancer	0.000241	0.00144	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—testicular cancer	0.000235	0.0014	CcSEcCtD
Perphenazine—Diarrhoea—Cisplatin—testicular cancer	0.000231	0.00138	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—testicular cancer	0.00023	0.00137	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—testicular cancer	0.000228	0.00136	CcSEcCtD
Perphenazine—Erythema—Methotrexate—testicular cancer	0.000227	0.00136	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000225	0.00134	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—testicular cancer	0.000223	0.00133	CcSEcCtD
Perphenazine—Pruritus—Etoposide—testicular cancer	0.000219	0.00131	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—testicular cancer	0.000214	0.00128	CcSEcCtD
Perphenazine—Erythema—Epirubicin—testicular cancer	0.000213	0.00127	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—testicular cancer	0.000212	0.00126	CcSEcCtD
Perphenazine—Dizziness—Etoposide—testicular cancer	0.000205	0.00122	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—testicular cancer	0.000204	0.00122	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—testicular cancer	0.000203	0.00121	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—testicular cancer	0.0002	0.0012	CcSEcCtD
Perphenazine—Cough—Methotrexate—testicular cancer	0.000198	0.00118	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—testicular cancer	0.000197	0.00117	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—testicular cancer	0.000197	0.00117	CcSEcCtD
Perphenazine—Agitation—Epirubicin—testicular cancer	0.000195	0.00117	CcSEcCtD
Perphenazine—Headache—Etoposide—testicular cancer	0.000194	0.00116	CcSEcCtD
Perphenazine—Syncope—Epirubicin—testicular cancer	0.000191	0.00114	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—testicular cancer	0.00019	0.00114	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—testicular cancer	0.000189	0.00113	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—testicular cancer	0.000187	0.00112	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—testicular cancer	0.000187	0.00111	CcSEcCtD
Perphenazine—Cough—Epirubicin—testicular cancer	0.000186	0.00111	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—testicular cancer	0.000185	0.00111	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—testicular cancer	0.000185	0.00111	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—testicular cancer	0.000184	0.0011	CcSEcCtD
Perphenazine—Infection—Methotrexate—testicular cancer	0.000184	0.0011	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—testicular cancer	0.000184	0.0011	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—testicular cancer	0.000181	0.00108	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—testicular cancer	0.000177	0.00106	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—testicular cancer	0.000177	0.00105	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—testicular cancer	0.000176	0.00105	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—testicular cancer	0.000176	0.00105	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—testicular cancer	0.000175	0.00104	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—testicular cancer	0.000174	0.00104	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—testicular cancer	0.000173	0.00103	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—testicular cancer	0.000173	0.00103	CcSEcCtD
Perphenazine—Infection—Epirubicin—testicular cancer	0.000172	0.00103	CcSEcCtD
Perphenazine—Cough—Doxorubicin—testicular cancer	0.000172	0.00102	CcSEcCtD
Perphenazine—Shock—Epirubicin—testicular cancer	0.000171	0.00102	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—testicular cancer	0.00017	0.00102	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—testicular cancer	0.00017	0.00101	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—testicular cancer	0.000169	0.00101	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—testicular cancer	0.000168	0.001	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—testicular cancer	0.000165	0.000987	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—testicular cancer	0.000165	0.000986	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—testicular cancer	0.000165	0.000983	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—testicular cancer	0.000164	0.000977	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—testicular cancer	0.000162	0.000967	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—testicular cancer	0.000162	0.000966	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—testicular cancer	0.000161	0.000962	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000161	0.000958	CcSEcCtD
Perphenazine—Infection—Doxorubicin—testicular cancer	0.00016	0.000952	CcSEcCtD
Perphenazine—Pain—Methotrexate—testicular cancer	0.000159	0.000946	CcSEcCtD
Perphenazine—Shock—Doxorubicin—testicular cancer	0.000158	0.000942	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—testicular cancer	0.000157	0.000936	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—testicular cancer	0.000157	0.000935	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—testicular cancer	0.000155	0.000923	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—testicular cancer	0.000154	0.00092	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—testicular cancer	0.000153	0.000913	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—testicular cancer	0.000151	0.0009	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—testicular cancer	0.00015	0.000895	CcSEcCtD
Perphenazine—Pain—Epirubicin—testicular cancer	0.000148	0.000885	CcSEcCtD
Perphenazine—Constipation—Epirubicin—testicular cancer	0.000148	0.000885	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—testicular cancer	0.000147	0.000879	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—testicular cancer	0.000147	0.000874	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—testicular cancer	0.000145	0.000866	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—testicular cancer	0.000143	0.000854	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—testicular cancer	0.000143	0.000852	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—testicular cancer	0.00014	0.000833	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—testicular cancer	0.000138	0.000822	CcSEcCtD
Perphenazine—Pain—Doxorubicin—testicular cancer	0.000137	0.000819	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—testicular cancer	0.000137	0.000819	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—testicular cancer	0.000137	0.000818	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—testicular cancer	0.000137	0.000815	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—testicular cancer	0.000131	0.000783	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—testicular cancer	0.000128	0.000763	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—testicular cancer	0.000128	0.000761	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—testicular cancer	0.000127	0.000757	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—testicular cancer	0.000127	0.000757	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—testicular cancer	0.000123	0.000732	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—testicular cancer	0.000123	0.000731	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—testicular cancer	0.000119	0.000708	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000118	0.000706	CcSEcCtD
Perphenazine—Headache—Methotrexate—testicular cancer	0.000116	0.000693	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—testicular cancer	0.000115	0.000685	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—testicular cancer	0.000114	0.000678	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—testicular cancer	0.00011	0.000655	CcSEcCtD
Perphenazine—Headache—Epirubicin—testicular cancer	0.000109	0.000649	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—testicular cancer	0.000106	0.000633	CcSEcCtD
Perphenazine—Headache—Doxorubicin—testicular cancer	0.000101	0.0006	CcSEcCtD
Perphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	3.75e-05	0.00281	CbGpPWpGaD
Perphenazine—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	3.73e-05	0.0028	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—INSL3—testicular cancer	3.68e-05	0.00276	CbGpPWpGaD
Perphenazine—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	3.62e-05	0.00271	CbGpPWpGaD
Perphenazine—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	3.61e-05	0.0027	CbGpPWpGaD
Perphenazine—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	3.61e-05	0.0027	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—INSL3—testicular cancer	3.56e-05	0.00267	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—INSL3—testicular cancer	3.56e-05	0.00267	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—INSL3—testicular cancer	3.52e-05	0.00264	CbGpPWpGaD
Perphenazine—AOX1—Metabolism—HPGDS—testicular cancer	3.52e-05	0.00264	CbGpPWpGaD
Perphenazine—CALM3—Downstream signal transduction—FGFR3—testicular cancer	3.51e-05	0.00263	CbGpPWpGaD
Perphenazine—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	3.5e-05	0.00262	CbGpPWpGaD
Perphenazine—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	3.5e-05	0.00262	CbGpPWpGaD
Perphenazine—CALM3—Signaling by FGFR—FGFR3—testicular cancer	3.49e-05	0.00262	CbGpPWpGaD
Perphenazine—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	3.47e-05	0.0026	CbGpPWpGaD
Perphenazine—CALM3—DAP12 signaling—FGFR3—testicular cancer	3.45e-05	0.00259	CbGpPWpGaD
Perphenazine—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	3.42e-05	0.00257	CbGpPWpGaD
Perphenazine—CALM1—Downstream signal transduction—FGFR3—testicular cancer	3.39e-05	0.00254	CbGpPWpGaD
Perphenazine—CALM2—Downstream signal transduction—FGFR3—testicular cancer	3.39e-05	0.00254	CbGpPWpGaD
Perphenazine—CALM2—Signaling by FGFR—FGFR3—testicular cancer	3.37e-05	0.00253	CbGpPWpGaD
Perphenazine—CALM1—Signaling by FGFR—FGFR3—testicular cancer	3.37e-05	0.00253	CbGpPWpGaD
Perphenazine—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	3.36e-05	0.00252	CbGpPWpGaD
Perphenazine—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	3.36e-05	0.00252	CbGpPWpGaD
Perphenazine—CALM2—DAP12 signaling—FGFR3—testicular cancer	3.34e-05	0.0025	CbGpPWpGaD
Perphenazine—CALM1—DAP12 signaling—FGFR3—testicular cancer	3.34e-05	0.0025	CbGpPWpGaD
Perphenazine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	3.31e-05	0.00248	CbGpPWpGaD
Perphenazine—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	3.31e-05	0.00248	CbGpPWpGaD
Perphenazine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	3.25e-05	0.00244	CbGpPWpGaD
Perphenazine—CALM3—DAP12 interactions—FGFR3—testicular cancer	3.25e-05	0.00244	CbGpPWpGaD
Perphenazine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	3.25e-05	0.00244	CbGpPWpGaD
Perphenazine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	3.22e-05	0.00241	CbGpPWpGaD
Perphenazine—CALM3—Downstream signal transduction—KIT—testicular cancer	3.22e-05	0.00241	CbGpPWpGaD
Perphenazine—CALM3—Signaling by FGFR—KIT—testicular cancer	3.2e-05	0.0024	CbGpPWpGaD
Perphenazine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	3.19e-05	0.00239	CbGpPWpGaD
Perphenazine—CALM3—Signaling by ERBB2—KIT—testicular cancer	3.19e-05	0.00239	CbGpPWpGaD
Perphenazine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	3.18e-05	0.00238	CbGpPWpGaD
Perphenazine—CALM3—DAP12 signaling—KIT—testicular cancer	3.17e-05	0.00238	CbGpPWpGaD
Perphenazine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	3.14e-05	0.00236	CbGpPWpGaD
Perphenazine—CALM2—DAP12 interactions—FGFR3—testicular cancer	3.14e-05	0.00236	CbGpPWpGaD
Perphenazine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	3.14e-05	0.00236	CbGpPWpGaD
Perphenazine—CALM1—DAP12 interactions—FGFR3—testicular cancer	3.14e-05	0.00236	CbGpPWpGaD
Perphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	3.14e-05	0.00236	CbGpPWpGaD
Perphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	3.14e-05	0.00236	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	3.12e-05	0.00234	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	3.12e-05	0.00234	CbGpPWpGaD
Perphenazine—CALM2—Downstream signal transduction—KIT—testicular cancer	3.11e-05	0.00233	CbGpPWpGaD
Perphenazine—CALM1—Downstream signal transduction—KIT—testicular cancer	3.11e-05	0.00233	CbGpPWpGaD
Perphenazine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	3.11e-05	0.00233	CbGpPWpGaD
Perphenazine—CALM1—Signaling by FGFR—KIT—testicular cancer	3.1e-05	0.00232	CbGpPWpGaD
Perphenazine—CALM2—Signaling by FGFR—KIT—testicular cancer	3.1e-05	0.00232	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	3.09e-05	0.00231	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	3.09e-05	0.00231	CbGpPWpGaD
Perphenazine—CALM1—Signaling by ERBB2—KIT—testicular cancer	3.08e-05	0.00231	CbGpPWpGaD
Perphenazine—CALM2—Signaling by ERBB2—KIT—testicular cancer	3.08e-05	0.00231	CbGpPWpGaD
Perphenazine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	3.07e-05	0.0023	CbGpPWpGaD
Perphenazine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	3.07e-05	0.0023	CbGpPWpGaD
Perphenazine—AOX1—Disease—H2AFZ—testicular cancer	3.07e-05	0.0023	CbGpPWpGaD
Perphenazine—CALM1—DAP12 signaling—KIT—testicular cancer	3.07e-05	0.0023	CbGpPWpGaD
Perphenazine—CALM2—DAP12 signaling—KIT—testicular cancer	3.07e-05	0.0023	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—INSL3—testicular cancer	3.03e-05	0.00227	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—INSL3—testicular cancer	3.01e-05	0.00226	CbGpPWpGaD
Perphenazine—CALM3—B Cell Activation—FGFR3—testicular cancer	3.01e-05	0.00225	CbGpPWpGaD
Perphenazine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	2.98e-05	0.00224	CbGpPWpGaD
Perphenazine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	2.98e-05	0.00224	CbGpPWpGaD
Perphenazine—CALM3—DAP12 interactions—KIT—testicular cancer	2.98e-05	0.00224	CbGpPWpGaD
Perphenazine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	2.98e-05	0.00224	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—KITLG—testicular cancer	2.98e-05	0.00223	CbGpPWpGaD
Perphenazine—CALM3—Signaling by EGFR—KIT—testicular cancer	2.96e-05	0.00222	CbGpPWpGaD
Perphenazine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	2.93e-05	0.0022	CbGpPWpGaD
Perphenazine—CALM3—Signaling by PDGF—KIT—testicular cancer	2.92e-05	0.00219	CbGpPWpGaD
Perphenazine—CALM1—B Cell Activation—FGFR3—testicular cancer	2.91e-05	0.00218	CbGpPWpGaD
Perphenazine—CALM2—B Cell Activation—FGFR3—testicular cancer	2.91e-05	0.00218	CbGpPWpGaD
Perphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	2.89e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM1—DAP12 interactions—KIT—testicular cancer	2.89e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	2.89e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	2.89e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM2—DAP12 interactions—KIT—testicular cancer	2.89e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	2.89e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	2.88e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	2.88e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—KITLG—testicular cancer	2.88e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—KITLG—testicular cancer	2.88e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	2.88e-05	0.00216	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR—KIT—testicular cancer	2.86e-05	0.00214	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR—KIT—testicular cancer	2.86e-05	0.00214	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	2.84e-05	0.00213	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	2.84e-05	0.00213	CbGpPWpGaD
Perphenazine—AOX1—Disease—KITLG—testicular cancer	2.83e-05	0.00212	CbGpPWpGaD
Perphenazine—CALM2—Signaling by PDGF—KIT—testicular cancer	2.82e-05	0.00212	CbGpPWpGaD
Perphenazine—CALM1—Signaling by PDGF—KIT—testicular cancer	2.82e-05	0.00212	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—BCL10—testicular cancer	2.82e-05	0.00211	CbGpPWpGaD
Perphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	2.78e-05	0.00209	CbGpPWpGaD
Perphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	2.78e-05	0.00209	CbGpPWpGaD
Perphenazine—CALM3—B Cell Activation—KIT—testicular cancer	2.76e-05	0.00207	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—BCL10—testicular cancer	2.73e-05	0.00204	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—BCL10—testicular cancer	2.73e-05	0.00204	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—BCL10—testicular cancer	2.71e-05	0.00203	CbGpPWpGaD
Perphenazine—CALM2—B Cell Activation—KIT—testicular cancer	2.67e-05	0.002	CbGpPWpGaD
Perphenazine—CALM1—B Cell Activation—KIT—testicular cancer	2.67e-05	0.002	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—INSL3—testicular cancer	2.66e-05	0.00199	CbGpPWpGaD
Perphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	2.64e-05	0.00198	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—BCL10—testicular cancer	2.62e-05	0.00196	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—BCL10—testicular cancer	2.62e-05	0.00196	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—INSL3—testicular cancer	2.62e-05	0.00196	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—INSL3—testicular cancer	2.61e-05	0.00196	CbGpPWpGaD
Perphenazine—AOX1—Metabolism—STK11—testicular cancer	2.56e-05	0.00192	CbGpPWpGaD
Perphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	2.56e-05	0.00192	CbGpPWpGaD
Perphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	2.56e-05	0.00192	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—INSL3—testicular cancer	2.38e-05	0.00178	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—HPGDS—testicular cancer	2.38e-05	0.00178	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.22e-05	0.00167	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—FGFR3—testicular cancer	2.21e-05	0.00166	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—INSL3—testicular cancer	2.17e-05	0.00163	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—FGFR3—testicular cancer	2.14e-05	0.00161	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—FGFR3—testicular cancer	2.14e-05	0.00161	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—INSL3—testicular cancer	2.1e-05	0.00158	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—INSL3—testicular cancer	2.1e-05	0.00158	CbGpPWpGaD
Perphenazine—AOX1—Disease—FGFR3—testicular cancer	2.1e-05	0.00157	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—KIT—testicular cancer	2.03e-05	0.00152	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.98e-05	0.00149	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—KIT—testicular cancer	1.97e-05	0.00147	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—KIT—testicular cancer	1.97e-05	0.00147	CbGpPWpGaD
Perphenazine—AOX1—Disease—KIT—testicular cancer	1.93e-05	0.00145	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.81e-05	0.00136	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—STK11—testicular cancer	1.73e-05	0.0013	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—KITLG—testicular cancer	1.7e-05	0.00127	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—KITLG—testicular cancer	1.64e-05	0.00123	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—KITLG—testicular cancer	1.64e-05	0.00123	CbGpPWpGaD
Perphenazine—CALM3—Immune System—BCL10—testicular cancer	1.64e-05	0.00123	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—KITLG—testicular cancer	1.63e-05	0.00122	CbGpPWpGaD
Perphenazine—CALM1—Immune System—BCL10—testicular cancer	1.59e-05	0.00119	CbGpPWpGaD
Perphenazine—CALM2—Immune System—BCL10—testicular cancer	1.59e-05	0.00119	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—KITLG—testicular cancer	1.58e-05	0.00118	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—KITLG—testicular cancer	1.58e-05	0.00118	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.55e-05	0.00116	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—H2AFZ—testicular cancer	1.31e-05	0.000982	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—H2AFZ—testicular cancer	1.31e-05	0.000981	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—STK11—testicular cancer	1.3e-05	0.000976	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—STK11—testicular cancer	1.3e-05	0.000975	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—FGFR3—testicular cancer	1.26e-05	0.000947	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—HPGDS—testicular cancer	1.25e-05	0.000935	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—FGFR3—testicular cancer	1.22e-05	0.000916	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—FGFR3—testicular cancer	1.22e-05	0.000916	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	1.21e-05	0.000909	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KITLG—testicular cancer	1.21e-05	0.000903	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KITLG—testicular cancer	1.2e-05	0.000902	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	1.17e-05	0.000879	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	1.17e-05	0.000879	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—HPGDS—testicular cancer	1.17e-05	0.000877	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—KIT—testicular cancer	1.16e-05	0.000869	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—HPGDS—testicular cancer	1.14e-05	0.000853	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—H2AFZ—testicular cancer	1.13e-05	0.000845	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—KIT—testicular cancer	1.12e-05	0.000841	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—KIT—testicular cancer	1.12e-05	0.000841	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—STK11—testicular cancer	1.12e-05	0.000841	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—KIT—testicular cancer	1.11e-05	0.000835	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—HPGDS—testicular cancer	1.1e-05	0.000825	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—HPGDS—testicular cancer	1.1e-05	0.000825	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—KIT—testicular cancer	1.08e-05	0.000807	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—KIT—testicular cancer	1.08e-05	0.000807	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KITLG—testicular cancer	1.04e-05	0.000778	CbGpPWpGaD
Perphenazine—CALM3—Disease—H2AFZ—testicular cancer	9.93e-06	0.000744	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—HPGDS—testicular cancer	9.9e-06	0.000742	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KITLG—testicular cancer	9.9e-06	0.000742	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	9.7e-06	0.000727	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	9.65e-06	0.000723	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—STK11—testicular cancer	9.64e-06	0.000723	CbGpPWpGaD
Perphenazine—CALM2—Disease—H2AFZ—testicular cancer	9.61e-06	0.00072	CbGpPWpGaD
Perphenazine—CALM1—Disease—H2AFZ—testicular cancer	9.61e-06	0.00072	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—STK11—testicular cancer	9.59e-06	0.000719	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KITLG—testicular cancer	9.57e-06	0.000718	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KITLG—testicular cancer	9.57e-06	0.000718	CbGpPWpGaD
Perphenazine—CALM3—Disease—KITLG—testicular cancer	9.14e-06	0.000685	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—STK11—testicular cancer	9.06e-06	0.000679	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—FGFR3—testicular cancer	8.96e-06	0.000671	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—FGFR3—testicular cancer	8.95e-06	0.000671	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KITLG—testicular cancer	8.92e-06	0.000669	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KITLG—testicular cancer	8.88e-06	0.000665	CbGpPWpGaD
Perphenazine—CALM2—Disease—KITLG—testicular cancer	8.84e-06	0.000663	CbGpPWpGaD
Perphenazine—CALM1—Disease—KITLG—testicular cancer	8.84e-06	0.000663	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—HPGDS—testicular cancer	8.84e-06	0.000662	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	8.51e-06	0.000638	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—STK11—testicular cancer	8.5e-06	0.000637	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STK11—testicular cancer	8.47e-06	0.000635	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	8.38e-06	0.000628	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	8.36e-06	0.000627	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STK11—testicular cancer	8.33e-06	0.000624	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STK11—testicular cancer	8.31e-06	0.000623	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—STK11—testicular cancer	8.27e-06	0.00062	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KIT—testicular cancer	8.22e-06	0.000616	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KIT—testicular cancer	8.21e-06	0.000616	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—HPGDS—testicular cancer	8.13e-06	0.000609	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—HPGDS—testicular cancer	8.06e-06	0.000604	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—STK11—testicular cancer	8e-06	0.0006	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—STK11—testicular cancer	8e-06	0.0006	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KITLG—testicular cancer	7.83e-06	0.000587	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—FGFR3—testicular cancer	7.71e-06	0.000578	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KITLG—testicular cancer	7.71e-06	0.000578	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KITLG—testicular cancer	7.69e-06	0.000577	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—H2AFZ—testicular cancer	7.62e-06	0.000571	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STK11—testicular cancer	7.58e-06	0.000568	CbGpPWpGaD
Perphenazine—CALM3—Immune System—FGFR3—testicular cancer	7.35e-06	0.000551	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—STK11—testicular cancer	7.19e-06	0.000539	CbGpPWpGaD
Perphenazine—CALM1—Immune System—FGFR3—testicular cancer	7.11e-06	0.000533	CbGpPWpGaD
Perphenazine—CALM2—Immune System—FGFR3—testicular cancer	7.11e-06	0.000533	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KIT—testicular cancer	7.08e-06	0.000531	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KITLG—testicular cancer	7.01e-06	0.000526	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	6.95e-06	0.000521	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STK11—testicular cancer	6.91e-06	0.000518	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—HPGDS—testicular cancer	6.89e-06	0.000516	CbGpPWpGaD
Perphenazine—CALM3—Disease—FGFR3—testicular cancer	6.79e-06	0.000509	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KIT—testicular cancer	6.75e-06	0.000506	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	6.73e-06	0.000504	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	6.73e-06	0.000504	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STK11—testicular cancer	6.69e-06	0.000501	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STK11—testicular cancer	6.69e-06	0.000501	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	6.63e-06	0.000497	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—FGFR3—testicular cancer	6.6e-06	0.000494	CbGpPWpGaD
Perphenazine—CALM2—Disease—FGFR3—testicular cancer	6.57e-06	0.000492	CbGpPWpGaD
Perphenazine—CALM1—Disease—FGFR3—testicular cancer	6.57e-06	0.000492	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KIT—testicular cancer	6.53e-06	0.00049	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KIT—testicular cancer	6.53e-06	0.00049	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—STK11—testicular cancer	6.42e-06	0.000481	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KITLG—testicular cancer	6.4e-06	0.00048	CbGpPWpGaD
Perphenazine—CALM3—Disease—KIT—testicular cancer	6.23e-06	0.000467	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KITLG—testicular cancer	6.19e-06	0.000464	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KITLG—testicular cancer	6.19e-06	0.000464	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KIT—testicular cancer	6.09e-06	0.000456	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KIT—testicular cancer	6.06e-06	0.000454	CbGpPWpGaD
Perphenazine—CALM2—Disease—KIT—testicular cancer	6.03e-06	0.000452	CbGpPWpGaD
Perphenazine—CALM1—Disease—KIT—testicular cancer	6.03e-06	0.000452	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—STK11—testicular cancer	5.91e-06	0.000443	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—STK11—testicular cancer	5.85e-06	0.000439	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—FGFR3—testicular cancer	5.82e-06	0.000436	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	5.73e-06	0.000429	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—FGFR3—testicular cancer	5.72e-06	0.000428	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KIT—testicular cancer	5.34e-06	0.000401	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HPGDS—testicular cancer	5.31e-06	0.000398	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KIT—testicular cancer	5.26e-06	0.000394	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KIT—testicular cancer	5.25e-06	0.000393	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—FGFR3—testicular cancer	5.21e-06	0.000391	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—STK11—testicular cancer	5e-06	0.000375	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KIT—testicular cancer	4.78e-06	0.000359	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—FGFR3—testicular cancer	4.75e-06	0.000356	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—FGFR3—testicular cancer	4.6e-06	0.000345	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—FGFR3—testicular cancer	4.6e-06	0.000345	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KIT—testicular cancer	4.37e-06	0.000327	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KIT—testicular cancer	4.22e-06	0.000317	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KIT—testicular cancer	4.22e-06	0.000317	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—STK11—testicular cancer	3.86e-06	0.000289	CbGpPWpGaD
